Back

Nano-engineered VEGF-C ameliorates gut lymphatic drainage, portal pressure and ascites in experimental portal hypertension

2020-12-27 gastroenterology Title + abstract only
View on medRxiv
Show abstract

Background and AimLymphatic vessels (LVs) are crucial for maintaining abdominal fluid homeostasis and immunity. In liver cirrhosis, mesenteric LVs (mLVs) are dilated and dysfunctional. Given an established protective role of VEGF-C in LVs, we hypothesized that VEGF-C treatment could improve functions of mLVs in cirrhosis. MethodIn this study, we developed a nanoformulation comprising LV-specific growth-factor, recombinant human VEGF-C(Cys156Ser) protein(E-VEGF-C) and delivered it orally in rat ...

Predicted journal destinations